Tag: CYP2C19

Pharmacogenomic Testing for SSRIs: How CYP2C19 and CYP2D6 Affect Side Effects

Pharmacogenomic Testing for SSRIs: How CYP2C19 and CYP2D6 Affect Side Effects
19/02
8

Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.

Read More...

Categories

Popular Articles

Direct Oral Anticoagulants vs. Warfarin: 2025 Efficacy, Monitoring & Latest Insights
Direct Oral Anticoagulants vs. Warfarin: 2025 Efficacy, Monitoring & Latest Insights

Apr 24 2025

Narrative Medicine: How Personal Stories Shape Acceptance of Generic Medications
Narrative Medicine: How Personal Stories Shape Acceptance of Generic Medications

Nov 12 2025

Renal Nutrition: Protein Targets for CKD Stages Explained
Renal Nutrition: Protein Targets for CKD Stages Explained

Dec 18 2025

Irbesartan Hydrochlorothiazide and Gout: Risks, Mechanisms, and Management
Irbesartan Hydrochlorothiazide and Gout: Risks, Mechanisms, and Management

Oct 17 2025

Measuring Your Medication Adherence: A Practical Checklist
Measuring Your Medication Adherence: A Practical Checklist

Nov 17 2025

Tags

PharmaCentral

Menu

© 2026. All rights reserved.